Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) Shares Outstanding (2020 - 2025)

LifeStance Health (LFST) has disclosed Shares Outstanding for 6 consecutive years, with $388.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 1.46% to $388.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $388.3 million, a 1.46% increase, with the full-year FY2025 number at $388.3 million, up 1.46% from a year prior.
  • Shares Outstanding was $388.3 million for Q4 2025 at LifeStance Health, roughly flat from $389.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $389.1 million in Q2 2025 to a low of $374149.0 in Q2 2021.
  • A 5-year average of $283.4 million and a median of $378.6 million in 2023 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: plummeted 99.08% in 2021, then surged 100965.22% in 2024.
  • LifeStance Health's Shares Outstanding stood at $374.3 million in 2021, then increased by 0.46% to $376.0 million in 2022, then grew by 0.73% to $378.7 million in 2023, then rose by 1.06% to $382.7 million in 2024, then increased by 1.46% to $388.3 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Shares Outstanding are $388.3 million (Q4 2025), $389.0 million (Q3 2025), and $389.1 million (Q2 2025).